Ambry CancerNext (Common Pan Cancer) Panel CancerNext
Synonyms |
|
Allscripts (AEHR) Order Name |
Ambry CancerNext (Common Cancer Panel) |
Sunrise Clinical Manager (SCM) Order Name |
Not Orderable |
EPIC Order Name |
|
Clinical Info |
Guideline-based, pan-cancer test that covers the most common hereditary cancer types, including hereditary breast, ovarian, pancreatic, prostate, colorectal/polyps, endometrial, gastric, small bowel, urothelial, and renal cancers. 40 genes are included in the analysis: APC, ATM, AXIN2, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, EPCAM, FH, FLCN, GREM1, HOXB13, MBD4, MET, MLH1, MSH2, MSH3, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS2, POLD1, POLE, PTEN, RAD51C, RAD51D, RPS20, SMAD4, STK11, TP53, TSC1, TSC2, VHL |
Specimen Type |
Blood, Swab |
Specimen Volume |
4mL |
Container |
Lavender Top Tube (EDTA whole blood) or Buccal Swab |
Collection Instructions |
Whole Blood |
Transport Instructions |
Room Temperature |
Specimen Stability |
72 Hours Room Temperature7 Days RefrigeratedBuccal Swab- 6 Days Room Temperature |
Methodology |
Next Generation Sequencing (NGS) |
Days Performed |
Monday-Saturday |
Performing Laboratories |
|
CPT |
81432 or 81435 |
PDM |
255307 |
Result InterpretationSee Report |
|
Forms |
|
